🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Narayana Hrudayalaya Limited NH NIFTY_SMALLNSEPHARMA

Healthcare · Medical Care Facilities · India
https://www.narayanahealth.org
Company Profile ↓
₹2,027.40
+3.15% 1Y
Mkt Cap₹41,432.11 Cr
P/E51.11
P/B9.12
Div. Yield0.22%
52W High₹2,043.20
52W Low₹1,605.30
Book Value₹222.02
EPS (TTM)₹39.67

Company Overview

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 17.8%, reflecting efficient use of shareholder capital.

Steady Revenue Expansion

Revenue has grown at a 20.7% CAGR over the past five years.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹7,896.03 Cr (+44.0% YoY); net profit ₹805.60 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +44.0%, earnings +1.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR 20.7%, profit CAGR 9.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:20.69%
1 Year:44.01%

Compounded Profit Growth

5 Years:9.94%
1 Year:1.95%

Stock Price Performance

1 Year:+3.15%
6 Months:+6.87%
3 Months:+13.79%
1 Month:+8.28%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 96% of range
₹1,605.30 ₹2,043.20
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)62.28 · Neutral
Price Performance
1M+8.28%
3M+13.79%
6M+6.87%
1Y+3.15%
Valuation vs Sector

P/E of 51.11 is above the sector median of 39.97 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 20.7% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 51.1.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
51.11
Industry PE
39.97
Forward P/E
28.91
PEG Ratio
-
Book Value
₹222.02
Price to Book
9.12
P/S
5.24
EV/EBITDA
27.63
Dividend Yield
0.22%

Growth (CAGR)

Revenue 5Y
20.69%
Profit 5Y
9.94%
Revenue (YoY)
44.01%
Earnings (YoY)
1.95%

Profitability & Returns

ROCE
11.39%
ROE
17.76%
ROA
6.46%
Profit Margin
10.20%
Op Margin
14.80%
Gross Margin
44.05%
EPS (Latest Qtr)
₹11.02
EPS (TTM)
₹39.67

Balance Sheet & Liquidity

Debt/Equity
1.29
Quick Ratio
2.07
Current Ratio
2.15
Debt
₹5,857.49 Cr
Total Assets
₹12,474.40 Cr
Current Assets
₹3,932.14 Cr
Working Capital
₹2,104.88 Cr

Ownership

Promoter Holding
67.23%
Chg in Prom Hold
3.96%
FII / Inst Holding
13.12%
Chg in FII Hold
-0.28%

Financial Snapshot

Enterprise Value
₹41,432.11 Cr
Total Revenue (TTM)
₹7,896.03 Cr
EBITDA
₹1,662.01 Cr
Free Cash Flow
₹746.01 Cr
Operating Cash Flow
₹1,621.19 Cr
Shares Outstanding
₹20.44 Cr
Gross Margin
44.05%
Payout Ratio
11.28%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NH Narayana Hrudayalaya Limited NIFTY_SMALLNSEPHARMA 2,027.40 51.11 ₹41,432.11 Cr 0.22% 11.39% 17.76% 20.69% 9.94%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 1,222.00 Cr1,233.00 Cr1,305.00 Cr1,204.00 Cr1,246.00 Cr1,306.00 Cr1,367.00 Cr1,335.00 Cr1,475.44 Cr1,507.27 Cr1,643.79 Cr2,151.17 Cr2,593.81 Cr
Cost of Revenue --------817.38 Cr845.51 Cr876.18 Cr1,199.42 Cr1,496.72 Cr
Gross Profit --------658.06 Cr661.76 Cr767.61 Cr951.75 Cr1,097.08 Cr
Operating Expenses 946.00 Cr963.00 Cr997.00 Cr925.00 Cr955.00 Cr1,004.00 Cr1,058.00 Cr1,027.00 Cr382.84 Cr409.11 Cr452.58 Cr706.77 Cr740.87 Cr
Operating Income 220.00 Cr212.00 Cr253.00 Cr216.00 Cr226.00 Cr241.00 Cr244.00 Cr237.00 Cr275.22 Cr252.65 Cr315.02 Cr244.99 Cr356.21 Cr
EBITDA 276.00 Cr271.00 Cr308.00 Cr279.00 Cr291.00 Cr302.00 Cr309.00 Cr307.00 Cr376.20 Cr360.30 Cr425.22 Cr337.64 Cr537.20 Cr
Interest Expense 21.00 Cr21.00 Cr23.00 Cr25.00 Cr28.00 Cr34.00 Cr35.00 Cr37.00 Cr40.68 Cr45.16 Cr42.26 Cr65.03 Cr91.28 Cr
Pretax Income 214.00 Cr206.00 Cr248.00 Cr209.00 Cr225.00 Cr231.00 Cr232.00 Cr219.00 Cr253.02 Cr230.84 Cr295.48 Cr150.36 Cr292.14 Cr
Tax Provision 40.66 Cr22.66 Cr22.32 Cr20.90 Cr33.75 Cr30.03 Cr32.48 Cr26.28 Cr56.78 Cr34.79 Cr37.19 Cr22.27 Cr64.11 Cr
Net Income 173.00 Cr184.00 Cr227.00 Cr188.00 Cr191.00 Cr202.00 Cr199.00 Cr193.00 Cr197.21 Cr196.65 Cr258.37 Cr126.70 Cr223.88 Cr
Diluted EPS 8.479.0011.099.209.339.859.729.449.719.6812.726.2411.02

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 1,364.00 Cr1,614.00 Cr1,878.00 Cr2,281.00 Cr2,861.00 Cr3,128.00 Cr2,583.00 Cr-4,491.06 Cr4,875.66 Cr5,482.98 Cr7,896.03 Cr
Cost of Revenue --------2,333.79 Cr2,437.44 Cr3,161.50 Cr4,417.83 Cr
Gross Profit --------2,157.27 Cr2,438.22 Cr2,321.47 Cr3,478.20 Cr
Operating Expenses 1,236.00 Cr1,434.00 Cr1,642.00 Cr2,064.00 Cr2,566.00 Cr2,694.00 Cr2,394.00 Cr-1,367.13 Cr1,500.48 Cr1,323.20 Cr2,309.33 Cr
Operating Income 60.00 Cr104.00 Cr156.00 Cr117.00 Cr158.00 Cr248.00 Cr5.00 Cr-790.14 Cr937.74 Cr998.27 Cr1,168.87 Cr
EBITDA 128.00 Cr180.00 Cr236.00 Cr217.00 Cr295.00 Cr434.00 Cr189.00 Cr-1,030.69 Cr1,223.01 Cr1,361.62 Cr1,662.01 Cr
Interest Expense 45.00 Cr33.00 Cr28.00 Cr55.00 Cr81.00 Cr94.00 Cr82.00 Cr-69.08 Cr96.88 Cr146.41 Cr243.74 Cr
Pretax Income 21.00 Cr51.00 Cr135.00 Cr80.00 Cr93.00 Cr161.00 Cr-56.00 Cr-751.58 Cr883.99 Cr935.54 Cr968.82 Cr
Tax Provision 14.91 Cr30.09 Cr52.65 Cr28.80 Cr34.41 Cr41.86 Cr42.00 Cr-145.01 Cr98.00 Cr145.72 Cr158.36 Cr
Net Income -19.00 Cr21.00 Cr83.00 Cr51.00 Cr59.00 Cr119.00 Cr-14.00 Cr-606.25 Cr789.26 Cr790.15 Cr805.60 Cr
Diluted EPS -0.841.044.062.512.905.82-0.70-29.8538.8638.9039.67

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 1,371.00 Cr1,557.00 Cr1,648.00 Cr2,529.00 Cr2,640.00 Cr2,901.00 Cr2,779.00 Cr-4,162.09 Cr5,624.58 Cr7,265.03 Cr12,474.40 Cr
Current Assets --------1,293.93 Cr1,946.06 Cr2,549.84 Cr3,932.14 Cr
Cash & Equivalents --------154.76 Cr263.83 Cr457.19 Cr770.07 Cr
Inventory --------71.57 Cr109.95 Cr110.26 Cr154.53 Cr
Receivables --------431.50 Cr421.88 Cr555.49 Cr655.66 Cr
Total Liabilities --------2,029.67 Cr2,739.49 Cr3,636.79 Cr7,934.88 Cr
Current Liabilities --------987.27 Cr1,110.38 Cr1,193.14 Cr1,827.25 Cr
Long Term Debt --------626.43 Cr1,195.06 Cr1,966.48 Cr4,667.18 Cr
Total Debt 362.00 Cr258.00 Cr217.00 Cr802.00 Cr813.00 Cr952.00 Cr826.00 Cr-884.17 Cr1,626.69 Cr2,428.37 Cr5,857.49 Cr
Total Equity 768.00 Cr876.00 Cr963.00 Cr1,035.00 Cr1,081.00 Cr1,136.00 Cr1,120.00 Cr-2,131.38 Cr2,883.68 Cr3,626.36 Cr4,537.26 Cr
Shares Outstanding --------20.44 Cr20.44 Cr20.44 Cr20.44 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 77.00 Cr174.00 Cr219.00 Cr182.00 Cr279.00 Cr443.00 Cr304.00 Cr-1,084.56 Cr1,066.60 Cr985.78 Cr1,621.19 Cr
Investing Cash Flow -223.00 Cr-150.00 Cr-146.00 Cr-520.00 Cr-162.00 Cr-189.00 Cr-113.00 Cr--1,174.10 Cr-1,457.94 Cr-1,325.32 Cr-3,699.90 Cr
Financing Cash Flow 140.00 Cr18.00 Cr-45.00 Cr315.00 Cr-27.00 Cr-247.00 Cr-194.00 Cr-87.74 Cr488.45 Cr544.31 Cr2,340.43 Cr
Capital Expenditure -92.00 Cr-88.00 Cr-134.00 Cr-202.00 Cr-150.00 Cr-114.00 Cr-69.00 Cr--522.04 Cr-970.61 Cr-1,081.96 Cr-875.18 Cr
Free Cash Flow -15.00 Cr86.00 Cr85.00 Cr-20.00 Cr129.00 Cr329.00 Cr235.00 Cr-562.52 Cr95.99 Cr-96.18 Cr746.01 Cr
Net Change in Cash -6.00 Cr42.00 Cr28.00 Cr-22.00 Cr89.00 Cr7.00 Cr-2.00 Cr--1.80 Cr97.11 Cr204.77 Cr261.72 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------48.0%50.0%42.3%44.0%
Operating Margin % 4.4%6.4%8.3%5.1%5.5%7.9%0.2%-17.6%19.2%18.2%14.8%
Net Margin % -1.4%1.3%4.4%2.2%2.1%3.8%-0.5%-13.5%16.2%14.4%10.2%
ROE % -2.5%2.4%8.6%4.9%5.5%10.5%-1.2%-28.4%27.4%21.8%17.8%
ROCE % --------24.9%20.8%16.4%11.0%

Shareholding Pattern

Insiders
67.23%
Institutions
13.12%
Public Float
40.04%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NH

Google News Mon, 13 Jul 2026

Be Sure To Check Out Narayana Hrudayalaya Limited (NSE:NH) Before It Goes Ex-Dividend - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbUZrN280Xzd4VllValhDTDJobDdaMmRQZVdRRkNQNmh6NVRwRTh3UVAwazFLXzBNYnFMTWtJWTFWMElPOVUwVlJubmxBVks3R29ZZHFnOHQ3UVBPMWd1NHFVemFpdE1Ob2hEQlBsaWw2aTd2YUFIS3pqVTlYUU5XbkVyVVFVNUhXbnRYMm…

Google News ue, 07 Jul 2026

Massachusetts lender to acquire NH bank for $160M - Banking Dive

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQmdMWF9sWUJLOEZWZThDemxRT1dqOXhGaldidkpqSDM1MGJmMTVKeUwydjJRVVhYa3E5MHI3U0FsejRDcDlpTjZUeWwwQ0NUUW14SS1FYXVhOXByRFloU2ktcXNBSnVNaXNLVzlXSzZOY19INWFfU28wRlhOODRLWnBNXy0zQzJiaGNv?o…

Google News Mon, 06 Jul 2026

bankESB parent buying NH bank, plans to convert from mutual to stock ownership - MassLive

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOamtudldDbzExOUNTVkNBRzd6VlBUaHg5c0ZtU2l3elNsMEJhbU9xVlhkTmdfV29NTG9yc2hTZHRyOUFESWdpZUJteTVxNHh6VjBIWGthTVpsRU1iTTNMN09oSTczS0RLVVJPT2hPVTFwQzhaaU1LSjNnekpqSDVkdVpwdV9iS2Y5RWRiWU…

Google News Wed, 08 Apr 2026

Running for Good - New Hampshire Magazine

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE1Xb3JLSHdfS1pSWVYtYWtoel8yWEoyUXBoNlpTY3BjU2JTa3FMUWM1TC0wQ1pRSVJGODRwQ21nYV9vN09DSWd6ZWh0YkhaaDRlOWk2VWF6NA?oc=5" target="_blank">Running for Good</a>&nbsp;&nbsp;<font color="#6f6…

Google News hu, 25 Jun 2026

NH Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1PRnN2YUpxS0ljYkFLaHhUeE50Z3Y2ZGE5ajZpc293TWliQVYxMTRvTXo0cnpfT0ltaFJOTHIwb2lOdnBDOWI2SlRadzFFQ2wxZHVybnpEa2dnM1JaQ2ExOVpmcHZhMThkTWdXbnBrQ2RiRlE?oc=5" target="_blank">NH Forecast …

Google News Fri, 26 Jun 2026

Goodlander Files Stock Trading And Predictions Market Bans For Congress, SCOTUS, White House - Patch

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQZWxxOC1zODE2ZXFtYzhaOEV2T0JhZG1hbGZRWGsxM2pReVlDSjhEdlNxV21KclNFSXpiVGh6VG5WaF9GVERBM3ZaeW5DWXdDVE1Cdm5NTlJnYnItS0wyRXQ5dC1DZWxLdjVoQWc3U1FxTU5Ib0FpZnlrUTZ3OFFCTVFyUkNYenJza0hTa0…

NH — Frequently Asked Questions

What is the current share price of Narayana Hrudayalaya Limited (NH)?

As of 2026-07-15 09:52 IST, Narayana Hrudayalaya Limited (NH) trades at ₹2,027.40 on NSE. Its 52-week range is ₹1,605.30 to ₹2,043.20.

What is the market capitalisation of NH?

Narayana Hrudayalaya Limited (NH) has a market capitalisation of ₹41,432.11 Cr on NSE.

What is the P/E ratio of NH?

NH trades at a trailing price-to-earnings (P/E) ratio of 51.11. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 9.12.

Does NH pay a dividend?

Narayana Hrudayalaya Limited (NH) currently offers a dividend yield of 0.22%.

What is the return on equity (ROE) of NH?

NH has a return on equity (ROE) of 17.76%. Its return on capital employed (ROCE) is 11.39%.

Is NH a good stock to buy?

This page provides a data-driven analysis of Narayana Hrudayalaya Limited (NH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space